» Articles » PMID: 22619696

The Bad, the Good, and the Ugly About Oxidative Stress

Overview
Publisher Wiley
Date 2012 May 24
PMID 22619696
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD), Parkinson's disease (PD), and cancer (e.g., leukemia) are the most devastating disorders affecting millions of people worldwide. Except for some kind of cancers, no effective and/or definitive therapeutic treatment aimed to reduce or to retard the clinic and pathologic symptoms induced by AD and PD is presently available. Therefore, it is urgently needed to understand the molecular basis of these disorders. Since oxidative stress (OS) is an important etiologic factor of the pathologic process of AD, PD, and cancer, understanding how intracellular signaling pathways respond to OS will have a significant implication in the therapy of these diseases. Here, we propose a model of minimal completeness of cell death signaling induced by OS as a mechanistic explanation of neuronal and cancer cell demise. This mechanism might provide the basis for therapeutic design strategies. Finally, we will attempt to associate PD, cancer, and OS. This paper critically analyzes the evidence that support the "oxidative stress model" in neurodegeneration and cancer.

Citing Articles

Effect of L. extract on growth performance, antioxidant capacity, and immune function in lambs.

Ma X, Niu Y, Nan S, Zhang W Front Vet Sci. 2024; 11:1367843.

PMID: 38659454 PMC: 11039921. DOI: 10.3389/fvets.2024.1367843.


Limited expression of Nrf2 in neurons across the central nervous system.

Levings D, Pathak S, Yang Y, Slattery M Redox Biol. 2023; 65:102830.

PMID: 37544245 PMC: 10428127. DOI: 10.1016/j.redox.2023.102830.


Limited Expression of in Neurons Across the Central Nervous System.

Levings D, Pathak S, Yang Y, Slattery M bioRxiv. 2023; .

PMID: 37214946 PMC: 10197674. DOI: 10.1101/2023.05.09.540014.


An antioxidant response element regulates the HIF1α axis in breast cancer cells.

Lacher S, Skon-Hegg C, Ruis B, Krznarich J, Slattery M Free Radic Biol Med. 2023; 204:243-251.

PMID: 37179033 PMC: 10321210. DOI: 10.1016/j.freeradbiomed.2023.05.003.


Shifting gears: Study of immune system parameters of male habitual marathon runners.

Panagoulias I, Charokopos N, Thomas I, Spantidea P, de Lastic A, Rodi M Front Immunol. 2023; 13:1009065.

PMID: 36713459 PMC: 9880332. DOI: 10.3389/fimmu.2022.1009065.


References
1.
Brewer G . Why vitamin E therapy fails for treatment of Alzheimer's disease. J Alzheimers Dis. 2010; 19(1):27-30. PMC: 3023173. DOI: 10.3233/JAD-2010-1238. View

2.
Vinish M, Anand A, Prabhakar S . Altered oxidative stress levels in Indian Parkinson's disease patients with PARK2 mutations. Acta Biochim Pol. 2011; 58(2):165-9. View

3.
Ichijo H, Nishida E, Irie K, Ten Dijke P, Saitoh M, Moriguchi T . Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 1997; 275(5296):90-4. DOI: 10.1126/science.275.5296.90. View

4.
McCord J, Fridovich I . Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969; 244(22):6049-55. View

5.
Martin H, Teismann P . Glutathione--a review on its role and significance in Parkinson's disease. FASEB J. 2009; 23(10):3263-72. DOI: 10.1096/fj.08-125443. View